Loading
Evoke Pharma Inc Stock: price and insider trades · United States
Evoke Pharma Inc: what insiders have been doing
Evoke Pharma Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). The last twelve months, up to 21 October 2026, brought 8 filings signed by 8 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €46k. One trade stands out by size: a sale of €46k from Klein Roger M., disclosed on 7 November 2025.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 8 filings, this issuer sits below that mark. The full history, which starts in 2025, counts no purchases against 2 sales.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€46,520
2 ops. · all time
Who traded when
BuySaleNantahala Capital Management, LLC1 sale
Roger M. Klein1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
Income statement
Revenue9.1M
Net income-4.8M-52.2% margin
Last declaration on 19 December 2025
Declarations12 total
148,153 shares@ US$11.00100.0% of flowCommon StockSEC:0001104659-25-123156:0
360 sharesCommon StockSEC:0001193125-25-322644:0
2,330 sharesCommon StockSEC:0001193125-25-322643:0
133 sharesCommon StockSEC:0001193125-25-322642:0
11,815 sharesCommon StockSEC:0001193125-25-322640:0
27 sharesCommon StockSEC:0001193125-25-322639:0
15,509 sharesCommon StockSEC:0001193125-25-322637:0
5,000 shares@ US$10.657100.0% of flowCommon StockSEC:0001651175-25-000005:0
1,000 shares@ US$2.79729.7% of flowCommon StockSEC:0000950170-25-043893:0
4,500 shares@ US$3.214100.0% of flowCommon StockSEC:0000950170-25-043880:0
6,849 shares@ US$3.6590.3% of flowCommon StockSEC:0000950170-25-030904:0
41 shares@ US$4.38710.0% of flowCommon StockSEC:0001104659-25-007682:0
12 of 12 declarations
About Evoke Pharma Inc
Evoke Pharma Inc is a biopharmaceutical company focused on developing treatments for gastrointestinal disorders. It is listed on the NASDAQ under the ticker symbol EVOK.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
